维普中文期刊产品整合服务
22篇 您的检索式:作者名="Kiser TH"
    题名 作者 年代 出处 被引量
1Treatment of hepatorenal syndrome显示文摘Kiser TH Maclaren R Fish DN 2009Pharmacotherapy2009,29,10:1
2A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal 显示文摘MUELLER SW PRESLASKI CR KISER TH et O1 2014Crit Care Med2014,42,5:1
3Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparinqnduced thrombocytopenia 显示文摘Kiser TH Jung R MacLaren R et aI 2005Pharmacotherapy2005,25,17:1
4Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy显示文摘Kiser TH MacLaren R Fish DN 2010Pharmacotherapy2010,30,11:1
5A randomized, doub-le-blind, placebo-controlled dose range study of dexmedetomidineas adjunctive therapy for alcohol withdrawal 显示文摘Mueller SW Preslaski CR Kiser TH 2014Crit Care Med2014,42,5:1
6Outcomes associ- ated with corticosteroid dosage in critically patients with acute exacerbations of chronic obstructive pulmonary dis- ease显示文摘Kiser TH Allen RR Valuck R J 2014Am JRespir Crit Care Med2014,189,9:1
7Evaluation of sulfobutylether- 显示文摘KISER TH FISH DN AQUILANTE CL 2015Crit Care2015,19,1:1
8Adjunctive dexmede- tomidine therapy in the intensive care unit: a retrospective assess- ment of impact on sedative and analgesic requirements,levels of sedation and analgesia, and ventilatory and hemodynamic para- meters显示文摘MacLAREN R FORREST LK KISER TH 2007Pharmacotherapy2007,27,3:1
9Treatment of hepatorenal syndrome 显示文摘Kiser TH Maelaren R Fish DN 2009Pharmacotherapy2009,29,10:1
10Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aemginosa 显示文摘Kiser TH Obritsch MD Jung R 2010Pharmacotherapy2010,30,:1
11Systemic anticoagulation consideration inchronic kidney disease 显示文摘Dager WE Kiser TH 2010Adv Chronic Kidney Dis2010,17,:1
12Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin -induced thrombocytopenia显示文摘Kiser TH Jung R MacLaren R 2005Pharmacotherapy2005,25,12:1
13Safety, efficacy, and do- sing requirements of bivalirudin in patients with heparin - in- duced thrombocytopenia 显示文摘Kiser TH Burch JC Klein PM 2008Pharmacotherapy2008,28,9:1
14Treatment of hepatorenal syndrome 显示文摘Kiser TH Maclaren R Fish DN 2009Pharmacotherapy2009,29,10:1
15Treatment of hepatorenal syndrome 显示文摘Kiser TH Maclaren R Fish DN 2009Pharmacotherapy2009,29,10:1
16Cerebral Vasospasm in Critically III Patients with Aneurysmal Subaraehnoid Hemorrhage:Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions 显示文摘Kiser TH 2014Hosp Pharm2014,49,10:1
17Treatment of hepatorenal syndrome 显示文摘Kiser TH Maclaren R Fish DN 2009Pharmaeotherapy2009,29,10:1
18Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease显示文摘Kiser TH Allen RR Valuck RJ 2014Am J Respir Crit Care Med2014,189,9:1
19Treatment of hepatorenal syndrome 显示文摘KISER TH MACLAREN R FISH DN 2009Pharmacotherapy2009,29,10:1
20A randomized, double- blind, placebo-controlled dose range study of dexmedetomidine as ad- junctive therapy for alcohol withdrawal显示文摘Mueller SW Preslaski CR Kiser TH 2014Crit Care Med2014,42,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费